Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

The inhibitor DPP can promote hair growth.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

PCOS is a common hormonal disorder causing irregular periods and increased hair growth, linked to insulin resistance and long-term health issues.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Women with PCOS are much more likely to experience depression.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 reinfection may trigger alopecia areata.

Patients with non-scarring hair loss often have emotional disorders.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.